Skip to main content

Discover more about ENTRESTO® 

Find educational resources to learn more about heart failure (HF) and ENTRESTO 

2022 AHA/ACC/HFSA HF Guideline Pocket Guide
2022 AHA/ACC/HFSA HF Guideline Pocket Guide
Switch In-Office Brochure Thumbnail

ENTRESTO Initiation Guide for Providers

Contact a Sales Specialist

If you're looking for more information about ENTRESTO, connect with one of our Sales Specialists. 

  • Clinical product information 

  • General access information 

  • Co-pay and adherence support options  

  • Sales Specialists do not have access to patient-level data 

Contact a Sales Specialist

*In PARAGON-HF, defined as LVEF ≥45% with structural heart disease (LAE or LVH); median LVEF was 57%. LVEF is a variable measure and the normal range can vary.1

ACC, American College of Cardiology; AHA, American Heart Association; HFSA, Heart Failure Society of America.

1. ENTRESTO [prescribing information]. East Hanover, NJ: Novartis Pharmaceuticals Corp.